Latest Close
$2.20
Stock Hub
AEMD
Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
-$29.80 (-93.12%)
Market Cap
$3,452,042.00
Sector
Healthcare
Industry
Medical Devices
Recommendation
none
52W Range
$1.36 to $32.00
Target Mean Price
$4.75
Beta
1.50
Trailing P/E
Not available
Forward P/E
-2.24
Price / Book
0.32
Company Overview
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.